GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC (XPAE:PHARMACARE) » Definitions » EV-to-EBITDA

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) EV-to-EBITDA : 44.93 (As of May. 16, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's enterprise value is $30.87 Mil. Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Dec. 2021 was $0.69 Mil. Therefore, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA for today is 44.93.

The historical rank and industry rank for Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA or its related term are showing as below:

XPAE:PHARMACARE's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14.79
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's stock price is $3.35. Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 was $0.021. Therefore, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's PE Ratio for today is 159.52.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals EV-to-EBITDA Historical Data

The historical data trend for Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals EV-to-EBITDA Chart

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.71 11.28 -44.50 6.85 6.05

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Sep21 Dec21
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.15 6.85 9.10 9.16 6.05

Competitive Comparison of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA falls into.



Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals EV-to-EBITDA Calculation

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=30.868/0.687
=44.93

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's current Enterprise Value is $30.87 Mil.
Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals  (XPAE:PHARMACARE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.35/0.021
=159.52

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's share price for today is $3.35.
Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.021.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 677, Ramallah, PSE
Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC is engaged in the manufacturing, selling, distribution, export and import of medicines, cosmetics, chemicals and veterinary products.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) Headlines

No Headlines